120 related articles for article (PubMed ID: 28844963)
1. Novel direct factor Xa inhibitory compounds from Tenebrio molitor with anti-platelet aggregation activity.
Lee W; Kim MA; Park I; Hwang JS; Na M; Bae JS
Food Chem Toxicol; 2017 Nov; 109(Pt 1):19-27. PubMed ID: 28844963
[TBL] [Abstract][Full Text] [Related]
2. Anti-factor Xa activities of zingerone with anti-platelet aggregation activity.
Lee W; Ku SK; Kim MA; Bae JS
Food Chem Toxicol; 2017 Jul; 105():186-193. PubMed ID: 28414123
[TBL] [Abstract][Full Text] [Related]
3. Novel factor Xa inhibitor, maslinic acid, with antiplatelet aggregation activity.
Kim KM; Kim J; Baek MC; Bae JS
J Cell Physiol; 2020 Dec; 235(12):9445-9456. PubMed ID: 32356316
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity.
Lee W; Lee H; Kim MA; Choi J; Kim KM; Hwang JS; Na M; Bae JS
Sci Rep; 2017 Aug; 7(1):7934. PubMed ID: 28801633
[TBL] [Abstract][Full Text] [Related]
5. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
Honda Y; Kamisato C; Morishima Y
Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
[TBL] [Abstract][Full Text] [Related]
6. A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates.
Chen M; Ye X; Ming X; Chen Y; Wang Y; Su X; Su W; Kong Y
Sci Rep; 2015 Jun; 5():10846. PubMed ID: 26035670
[TBL] [Abstract][Full Text] [Related]
7. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet Aggregation Properties of Cirsilineol: A Novel Inhibitor of Blood Coagulation Factor Xa.
Kim GO; Heo JB; Park DH; Song GY; Bae JS
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111345
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N²-Thiophenecarbonyl- and N²-Tosylanthranilamides.
Lee SH; Lee W; Nguyen T; Um IS; Bae JS; Ma E
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561744
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of factor Xa activity, platelet aggregation, and experimentally induced thrombosis by Sparstolonin B.
Kim N; Jeon C; Kim C; Ryu SH; Lee W; Bae JS
Phytomedicine; 2022 May; 99():153987. PubMed ID: 35183932
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
[TBL] [Abstract][Full Text] [Related]
13. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase.
Tsujimoto M; Kuroyanagi G; Matsushima-Nishiwaki R; Kito Y; Enomoto Y; Iida H; Ogura S; Otsuka T; Tokuda H; Kozawa O; Iwama T
PLoS One; 2016; 11(2):e0149077. PubMed ID: 26867010
[TBL] [Abstract][Full Text] [Related]
15. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.
Xiang K; Liu G; Zhou YJ; Hao HZ; Yin Z; He AD; Da XW; Xiang JZ; Wang JL; Ming ZY
Thromb Res; 2014 Feb; 133(2):211-7. PubMed ID: 24332167
[TBL] [Abstract][Full Text] [Related]
16. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
17. A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca²⁺-independent manner.
Mukherjee AK; Dutta S; Mackessy SP
Thromb Res; 2014 Nov; 134(5):1150-6. PubMed ID: 25281435
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical pharmacodynamic study of a novel oral factor Xa inhibitor zifaxaban.
Qiu X; Wang W; Zhao Z; Sun S; Tang L
Eur J Pharmacol; 2018 Oct; 836():50-56. PubMed ID: 30125563
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided creation of AcAP5-derived and platelet targeted factor Xa inhibitors.
Zhu Y; Lin Y; Liu A; Shui M; Li R; Liu X; Hu W; Wang Y
Biochem Pharmacol; 2015 Jun; 95(4):253-62. PubMed ID: 25887920
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population.
Veach D; Hosking H; Thompson K; Santhakumar AB
Food Funct; 2016 Aug; 7(8):3609-16. PubMed ID: 27480079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
